BIOLINERX LTD's ticker is BLRXXXXX and the CUSIP is 09071M106. A total of 29 filers reported holding BIOLINERX LTD in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $31,000 | +29.2% | 86,595 | +50.3% | 0.00% | – |
Q1 2019 | $24,000 | -52.0% | 57,628 | -50.0% | 0.00% | – |
Q4 2018 | $50,000 | -18.0% | 115,256 | +100.0% | 0.00% | – |
Q3 2018 | $61,000 | +17.3% | 57,628 | 0.0% | 0.00% | – |
Q2 2018 | $52,000 | +136.4% | 57,628 | +126.8% | 0.00% | – |
Q1 2018 | $22,000 | -18.5% | 25,413 | 0.0% | 0.00% | – |
Q4 2017 | $27,000 | -3.6% | 25,413 | 0.0% | 0.00% | – |
Q3 2017 | $28,000 | +33.3% | 25,413 | 0.0% | 0.00% | – |
Q2 2017 | $21,000 | -12.5% | 25,413 | 0.0% | 0.00% | – |
Q1 2017 | $24,000 | – | 25,413 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 1,451,000 | $3,236,000 | 2.39% |
SPHERA FUNDS MANAGEMENT LTD. | 600,000 | $1,338,000 | 0.30% |
BVF INC/IL | 800,000 | $1,784,000 | 0.28% |
Senvest Management, LLC | 1,549,805 | $3,456,000 | 0.27% |
SABBY MANAGEMENT, LLC | 1,902,800 | $4,243,000 | 0.24% |
Perceptive Advisors | 179,041 | $399,000 | 0.04% |
Orbimed Advisors | 1,135,000 | $2,531,000 | 0.03% |
Benchmark Capital Advisors | 20,000 | $45,000 | 0.03% |
JANE STREET GROUP, LLC | 59,063 | $130,000 | 0.00% |
Virtu KCG Holdings LLC | 18,640 | $41,000 | 0.00% |